Unknown

Dataset Information

0

Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis.


ABSTRACT: Human herpesvirus (HHV)-6A or HHV-6B involvement in multiple sclerosis (MS) etiology has remained controversial mainly due to the lack of serological methods that can distinguish the two viruses. A novel multiplex serological assay measuring IgG reactivity against the immediate-early protein 1 from HHV-6A (IE1A) and HHV-6B (IE1B) was used in a MS cohort (8,742 persons with MS and 7,215 matched controls), and a pre-MS cohort (478 individuals and 476 matched controls) to investigate this further. The IgG response against IE1A was positively associated with MS (OR = 1.55, p = 9 × 10-22), and increased risk of future MS (OR = 2.22, p = 2 × 10-5). An interaction was observed between IE1A and Epstein-Barr virus (EBV) antibody responses for MS risk (attributable proportion = 0.24, p = 6 × 10-6). In contrast, the IgG response against IE1B was negatively associated with MS (OR = 0.74, p = 6 × 10-11). The association did not differ between MS subtypes or vary with severity of disease. The genetic control of HHV-6A/B antibody responses were located to the Human Leukocyte Antigen (HLA) region and the strongest association for IE1A was the DRB1*13:01-DQA1*01:03-DQB1*06:03 haplotype while the main association for IE1B was DRB1*13:02-DQA1*01:02-DQB1*06:04. In conclusion a role for HHV-6A in MS etiology is supported by an increased serological response against HHV-6A IE1 protein, an interaction with EBV, and an association to HLA genes.

SUBMITTER: Engdahl E 

PROVIDER: S-EPMC6988796 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications


Human herpesvirus (HHV)-6A or HHV-6B involvement in multiple sclerosis (MS) etiology has remained controversial mainly due to the lack of serological methods that can distinguish the two viruses. A novel multiplex serological assay measuring IgG reactivity against the immediate-early protein 1 from HHV-6A (IE1A) and HHV-6B (IE1B) was used in a MS cohort (8,742 persons with MS and 7,215 matched controls), and a pre-MS cohort (478 individuals and 476 matched controls) to investigate this further.  ...[more]

Similar Datasets

| S-EPMC8055650 | biostudies-literature
| S-EPMC6291489 | biostudies-literature
| S-EPMC6606781 | biostudies-literature
| S-EPMC1829265 | biostudies-literature
2013-10-22 | E-GEOD-45917 | biostudies-arrayexpress
2019-08-15 | GSE121987 | GEO
| S-EPMC2882210 | biostudies-literature
| S-EPMC3505605 | biostudies-literature
| S-EPMC112820 | biostudies-literature
| S-EPMC8638856 | biostudies-literature